000225.KS

Yuyu Pharma, Inc.

HealthcareDrug Manufacturers - Specialty & GenericKRKRWPeers →Country macro →

$3,595.00

-1.37%Jun 19, 2026

AI Brief

Market cap

$59.84B

52w range

—

P / E

—

EPS

—

Volume

—

Revenue · FY

—

Overview Fundamentals Valuation Market Narrative & AI

Explain this page

Arphra AIPlain-English read on Yuyu Pharma, Inc.’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$3595.00

Change

-30.33%

Period high

$5250.00

Period low

$3595.00

Period start

$5160.002025-06-25

Through 2026-06-19

Fair value

Football field →

Weighted blend

—

— vs spot

Recommendation

n/a

0 of 0 methods

Method spread

0bull0bear

±5% threshold

Candlestick · 1Y

Open in chart workstation →

000225.KS

3,595-30.33%

H 5,700L 3,470MA50 4,192MA200 4,618Avg vol 25K

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Sector & industry today

Live

Sectors

Real Estate
+1.26%
Utilities
+0.96%
Consumer Cyclical
+0.94%
Energy
+0.84%
Financial Services
+0.65%
Basic Materials
-0.11%
Communication Services
-0.40%
Healthcare
-0.41%
Industrials
-0.47%
Technology
-0.80%
Consumer Defensive
-1.00%

Top industries (issuer's industry highlighted)

Drug Manufacturers - Specialty & Generic
+0.88%
Biotechnology
+6.56%
Financial - Mortgages
-4.05%
Home Improvement
+3.89%
Electrical Equipment & Parts
+3.88%
Paper, Lumber & Forest Products
+3.53%
Software - Services
-3.30%
Software - Infrastructure
-3.07%
Financial - Conglomerates
+2.62%
Auto - Dealerships
+2.54%
Luxury Goods
+2.47%
Auto - Recreational Vehicles
+2.22%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for 000225.KS.

Financial scores

DBJun 20, 2026

Altman Z

1.87

Grey

≥ 3.0 safe · 1.81–3.0 grey · < 1.81 distress

Piotroski F

8/9

Strong

≥ 7 strong · 4–6 average · < 4 weak

Peers

No peer list available for 000225.KS.

Total assets

—

Total debt

—

Cash & equiv

—

Operating CF

—

Free cash flow

—

Buybacks

—

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin